Bayer begins inhibitor study treating advanced KRAS-mutated tumours - PharmaTimes Trial explores potential of therapy in treating multiple cancer types

#Bayer #precisiononcology #oncology #SOS1inhibitorstudy #BAY3498264 #KRASmutatedcancers #nonsmallcelllungcancer #lungcancer #NSCLC #pancreaticcancer #colorectalcancer #MAPKsignallingpathway #KRAStargetingagent #KRASmutatedcancers #solidtumours
pharmatimes.com/news/bayer-b...